/

Geron

Develops and sells telomerase inhibitor treatments for blood cancers.

BiotechnologyPharmaceuticals geron.com ↗

Company facts

Founded: 1990
Employees: 230
Headquarters: United States
Type: Public
Listed: Nasdaq: GERN